These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 15918961)
1. [Targeted therapy for primary hepatocellular carcinoma]. Ye SL Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):322-3. PubMed ID: 15918961 [No Abstract] [Full Text] [Related]
2. Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2. Schepelmann S; Hallenbeck P; Ogilvie LM; Hedley D; Friedlos F; Martin J; Scanlon I; Hay C; Hawkins LK; Marais R; Springer CJ Cancer Res; 2005 Jun; 65(12):5003-8. PubMed ID: 15958540 [TBL] [Abstract][Full Text] [Related]
3. [Gene therapy of hepatocellular carcinoma]. Wang XH; Li GQ Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):691-2. PubMed ID: 15623383 [No Abstract] [Full Text] [Related]
4. [Gene therapy for hepatocellular carcinoma]. Lin JS Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):756. PubMed ID: 14697144 [No Abstract] [Full Text] [Related]
5. [Gene therapy of hepatocellular carcinoma]. Lin JS; Chang Y Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):69-70. PubMed ID: 18226353 [No Abstract] [Full Text] [Related]
6. Gene therapy for hepatocellular carcinoma. Aggarwal A; Aggarwal R Natl Med J India; 1992; 5(4):171-2. PubMed ID: 1338969 [No Abstract] [Full Text] [Related]
7. Gene therapy for hepatocellular carcinoma-teaching old dogs new tricks. Afford SC; Young LS Hepatology; 2001 Jul; 34(1):207-9. PubMed ID: 11431753 [No Abstract] [Full Text] [Related]
8. [Expression of epidermal growth factor and its receptor in human primary hepatocellular carcinoma]. Wu X; Peng L Hunan Yi Ke Da Xue Xue Bao; 1997; 22(6):544-6. PubMed ID: 10073004 [No Abstract] [Full Text] [Related]
9. [Current status of immuno-gene therapy for hepatocellular carcinoma]. Ye S Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):407-8. PubMed ID: 12502436 [No Abstract] [Full Text] [Related]
10. [The application of RNAi in hepatocellular carcinoma]. Huang J; Lin JS Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):556. PubMed ID: 15387912 [No Abstract] [Full Text] [Related]
11. [An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors]. Lang A; Graeven U Zentralbl Chir; 2009 Jun; 134(3):189-92. PubMed ID: 19544236 [No Abstract] [Full Text] [Related]
12. Angiostatin and hepatocellular carcinoma. Soff G Hepatology; 2003 Mar; 37(3):505-6. PubMed ID: 12601345 [No Abstract] [Full Text] [Related]
13. [Hepatocarcinoma: from epidemiology to gene therapy]. Picardi A Clin Ter; 2000; 151(2):65-6. PubMed ID: 10876969 [No Abstract] [Full Text] [Related]
14. Interleukin-12 gene therapy for hepatocellular carcinoma: a dream come true? Tsai SL J Gastroenterol Hepatol; 2004 Oct; 19(10):1097-100. PubMed ID: 15377285 [No Abstract] [Full Text] [Related]
15. Successful targeted therapies for hepatocellular carcinoma: are we really getting there? Zhu AX Expert Rev Anticancer Ther; 2008 Apr; 8(4):499-505. PubMed ID: 18402516 [No Abstract] [Full Text] [Related]
16. New drugs for the treatment of hepatocellular carcinoma. Boucher E; Forner A; Reig M; Bruix J Liver Int; 2009 Jan; 29 Suppl 1():148-58. PubMed ID: 19207980 [TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis and targeted therapy of hepatocellular carcinoma. Zender L; Kubicka S Onkologie; 2008 Oct; 31(10):550-5. PubMed ID: 18854656 [TBL] [Abstract][Full Text] [Related]